Detalles de la búsqueda
1.
Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency.
N Engl J Med
; 390(12): 1105-1117, 2024 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38507753
2.
Phase 1 trial of CV301 in combination with anti-PD-1 therapy in nonsquamous non-small cell lung cancer.
Int J Cancer
; 152(3): 447-457, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36054490
3.
Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis.
Ann Rheum Dis
; 82(6): 829-836, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36801811
4.
Dataset for reporting of thymic epithelial tumours: recommendations from the International Collaboration on Cancer Reporting (ICCR).
Histopathology
; 83(6): 967-980, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37722860
5.
Joint-Predominant Rheumatic Complications of Immune Checkpoint Inhibitor Therapy in Patients with Thymic Epithelial Tumors.
Oncologist
; 27(4): e353-e356, 2022 04 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35380721
6.
Unraveling the Pharmaceutical Benefits of Freshly Prepared Amino Acid-Based Schiff Bases Via DFT, In Silico Molecular Docking and ADMET.
J Fluoresc
; 32(5): 1873-1888, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35749028
7.
COVID19 in children with cancer in low- and middle-income countries: Experience from a cancer center in Chennai, India.
Pediatr Hematol Oncol
; 38(2): 161-167, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33150828
8.
Olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced vomiting in children: An open-label, randomized phase 3 trial.
Pediatr Blood Cancer
; 67(9): e28532, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32568452
9.
Comparison of Eight Technologies to Determine Genotype at the UGT1A1 (TA)n Repeat Polymorphism: Potential Clinical Consequences of Genotyping Errors?
Int J Mol Sci
; 21(3)2020 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-32019188
10.
Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy.
Oncologist
; 24(9): 1259-1269, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30996010
11.
A Pilot Study of Sirolimus in Subjects with Cowden Syndrome or Other Syndromes Characterized by Germline Mutations in PTEN.
Oncologist
; 24(12): 1510-e1265, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31350329
12.
Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lung.
Anticancer Drugs
; 29(5): 457-465, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29420340
13.
Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial.
Lancet Oncol
; 18(5): 599-610, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28373005
14.
Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial.
Lancet Oncol
; 18(5): 587-598, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28373007
15.
Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial.
Lancet Oncol
; 16(2): 177-86, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25592632
16.
Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial.
Lancet Oncol
; 15(2): 191-200, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24439931
17.
A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinib.
Cancer
; 120(8): 1145-54, 2014 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24501009
18.
Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1.
Ann Rheum Dis
; 78(1): 150-152, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30185415
19.
Immunotherapy for Thymomas and Thymic Carcinomas: Current Status and Future Directions.
Cancers (Basel)
; 16(7)2024 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38611047
20.
Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-ß and PD-L1, in patients with advanced non-small cell lung cancer.
J Immunother Cancer
; 12(3)2024 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38485188